Axa S.A. Amphastar Pharmaceuticals, Inc. Transaction History

Axa S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $107,125 - $158,625	-2,500 Reduced 7.77%	29,678 $1.3 Million
Q4 2023 Jul 16, 2024	BUY	$44.49 - $62.93 $111,225 - $157,325	2,500 Added 8.42%	32,178 $1.99 Million
Q4 2023 Feb 14, 2024	SELL	$44.49 - $62.93 $1.37 Million - $1.93 Million	-30,722 Reduced 48.84%	32,178 $1.99 Million
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $577,977 - $825,500	-12,700 Reduced 16.8%	62,900 $2.89 Million
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $2.73 Million - $4.45 Million	-76,255 Reduced 50.22%	75,600 $4.34 Million
Q1 2023 May 15, 2023	BUY	$27.99 - $37.92 $68,547 - $92,866	2,449 Added 1.64%	151,855 $5.69 Million
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $87,728 - $98,219	3,141 Added 2.15%	149,406 $4.19 Million
Q3 2022 Feb 14, 2023	BUY	$27.56 - $37.75 $1.83 Million - $2.51 Million	66,396 Added 83.13%	146,265 $4.11 Million
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $1.83 Million - $2.51 Million	66,396 Added 83.13%	146,265 $4.11 Million
Q2 2022 Feb 14, 2023	SELL	$29.79 - $42.29 $1.98 Million - $2.81 Million	-66,396 Reduced 45.39%	79,869 $2.78 Million
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $2.38 Million - $3.38 Million	79,869 New	79,869 $2.78 Million

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.